الستيروئيدات القشرية الانشاقية وخطر الداء السكري عند المسنين
Abstract
أجريت هذه الدراسة في قسم الأمراض الباطنة لمشفى الأسد الجامعي في اللاذقية خلال العام 2008-2009، وشملت 70 مريضاً مسناً يعانون من آفات قصبية انسدادية مزمنة، ويستخدمون الستيروئيدات القشرية الانشاقية ولا يشكون من داء سكري مثبت ومعالج عند دخولهم الدراسة, إذ تم تقسيم المرضى إلى مجموعتين:
الأولى: مستخدمي الستيروئيد القشري الانشاقي لوحده.الثانية: مستخدمي الستيروئيد القشري الانشاقي مع التعرض للستيروئيد القشري الجهازي,كماتم التمييز بين مستخدمي الجرعات الدنيا والعليا من الستيروئيد القشري الانشاقي في كلا المجموعتين, عندئذٍ تمت مراقبة المرضى لتحري تطور داء سكري لديهم.
إذ تبين تطور داء سكري مثبت ومعالج بنسبة قليلة جداًهي:مريض واحد(2,6%) لمرضى المجموعة الأولى ومريض واحد (4,5%) لمرضى المجموعة الثانية كذلك لاحظنا زيادة نسبة الإصابة بالداء السكري باستخدام الجرعات العالية من الستيروئيد القشري الإنشاقي.
This study was carried out in the Department of Internal Medicine at Al-Assad University Hospital in Lattakia during the year 2008-2009, and included 70 patients with COPD (Chronic Obstructive Pulmonary Disease); they were using inhaled corticosteroids but had no diabetes. Then, we divided them into two groups: The first included the users of inhaled corticosteroids alone. The second included the users of inhaled corticosteroids who had been exposed to systemic corticosteroids; in such groups, we referred to the users of low and high doses of inhaled corticosteroids in both groups, We found diagnostic diabetes at a very low percentage: of patients of the first group, 1 patient (2.6%) and of patients of the second, 1 patient(4.5%). We noticed that diabetes increased by using high doses of inhaled corticosteroids.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
